share_log

Baird Upgrades Medpace Hldgs to Outperform, Raises Price Target to $289

Benzinga ·  Oct 24, 2023 06:17

Baird analyst Eric Coldwell upgrades Medpace Hldgs (NASDAQ:MEDP) from Neutral to Outperform and raises the price target from $270 to $289.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment